Edition:
United Kingdom

ADMA Biologics Inc (ADMA.OQ)

ADMA.OQ on NASDAQ Stock Exchange Capital Market

3.24USD
15 Jan 2019
Change (% chg)

-- (--)
Prev Close
$3.24
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
53,334
52-wk High
$6.96
52-wk Low
$2.08

Chart for

About

ADMA Biologics, Inc. is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments... (more)

Overall

Beta: 2.10
Market Cap(Mil.): $82.28
Shares Outstanding(Mil.): 25.79
Dividend: --
Yield (%): --

Financials

  ADMA.OQ Industry Sector
P/E (TTM): -- 69.71 34.38
EPS (TTM): -1.75 -- --
ROI: -51.15 8.99 14.96
ROE: -154.84 10.14 16.53

UPDATE 1-FDA declines to approve re-launch of ADMA Biologics' Bivigam

Dec 19 The U.S. Food and Drug Administration (FDA)on Wednesday declined to approve ADMA Biologics Inc's application to re-launch its immune deficiency treatment Bivigam, the company said.

19 Dec 2018

FDA declines to approve re-launch of ADMA Biologics' Bivigam

Dec 19 The U.S. Food and Drug Administration on Wednesday declined to approve ADMA Biologics Inc's application to re-launch its immune deficiency treatment Bivigam, the company said.

19 Dec 2018

Earnings vs. Estimates